Edinburgh, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of a dry powder inhaler designed to assist with inhalable medications. 1nhaler is based in Edinburgh, United Kingdom and was founded in 2017. Its last reported valuation was $13.8 million in Nov 2025. It has raised $4.5 million.
Last reported valuation
$13.8M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
—
Cap table — not yet on record
1nhaler's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of 1nhaler with a free account
·Watch 1nhaler: the Monday email on marks, rounds and moves
